We are advised by Pharos Capital Group that journalists and other readers should disregard the news release, Pharos Capital Makes Majority Investment in RhythMedix, issued 04-Jan-2024 over PR Newswire.
SOURCE Pharos Capital Group
https://rt.newswire.ca/rt.gif?NewsItemId=DE03983A&Transmission_Id=202510021712PR_NEWS_USPR_____DE03983A&DateId=20251002